AMERICAN INTERNATIONAL GROUP, INC. - KALVISTA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$118,353
+10.9%
12,290
+3.7%
0.00%0.0%
Q2 2023$106,677
+14.9%
11,853
+0.3%
0.00%0.0%
Q1 2023$92,858
+18.6%
11,814
+2.0%
0.00%0.0%
Q4 2022$78,274
-53.7%
11,579
-0.4%
0.00%0.0%
Q3 2022$169,000
+49.6%
11,621
+1.4%
0.00%0.0%
Q2 2022$113,000
-31.1%
11,456
+3.0%
0.00%0.0%
Q1 2022$164,000
+4.5%
11,119
-6.6%
0.00%0.0%
Q4 2021$157,000
-17.4%
11,901
+9.4%
0.00%0.0%
Q3 2021$190,000
-28.8%
10,880
-2.3%
0.00%0.0%
Q2 2021$267,000
-6.3%
11,139
+0.3%
0.00%0.0%
Q1 2021$285,000
+77.0%
11,105
+30.9%
0.00%0.0%
Q4 2020$161,000
+56.3%
8,486
+4.1%
0.00%–
Q3 2020$103,000
+2.0%
8,154
-2.2%
0.00%–
Q2 2020$101,000
+77.2%
8,340
+11.6%
0.00%–
Q1 2020$57,000
-59.6%
7,472
-5.5%
0.00%
-100.0%
Q4 2019$141,000
+64.0%
7,903
+7.2%
0.00%–
Q3 2019$86,000
-47.6%
7,371
-0.7%
0.00%
-100.0%
Q2 2019$164,000–7,421–0.00%–
 Download
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Saturn V Capital Management LP 719,937$6,697,4595.56%
TCG Crossover Management, LLC 3,395,495$22,953,5464.05%
VR Adviser, LLC 2,916,667$19,716,6693.32%
TANG CAPITAL MANAGEMENT LLC 3,196,446$21,607,9753.14%
Prosight Management, LP 621,667$4,202,4692.29%
Opaleye Management Inc. 923,200$6,240,8322.17%
GREAT POINT PARTNERS LLC 1,055,801$7,137,2151.40%
Frazier Life Sciences Management, L.P. 3,238,859$21,894,6871.36%
DAFNA Capital Management LLC 616,032$4,164,3761.17%
Vivo Capital, LLC 856,008$5,7870.67%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders